Global consulting giant McKinsey & Company has agreed to a $650 million settlement after admitting to advising Purdue Pharma on boosting sales of the addictive opioid OxyContin. The settlement addresses McKinsey’s role in turbocharging opioid sales despite knowing the risks, contributing to an epidemic that has claimed over 100,000 lives annually in the U.S. This agreement also resolves charges of record destruction and false claims related to medically unnecessary prescriptions. A sobering reminder of the devastating opioid crisis.
#OpioidCrisis #McKinseySettlement #OxyContin #BreakingNews #Newscazt #JusticeDepartment #PublicHealthCrisis #PurduePharma #Accountability #DrugEpidemic
